Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naive pediatric patients with Crohn's disease in clinical practice

被引：0

作者：

Steiner, S. ^{[1
]}

King, E. ^{[2
]}

Park, K. ^{[3
]}

Pashankar, D. ^{[4
]}

Shashidhar, H. ^{[5
]}

Sudel, B. ^{[6
]}

Eichner, S. ^{[7
]}

Chen, S. ^{[2
]}

Pratt, J. ^{[2
]}

Colletti, R. ^{[8
]}

机构：

[1] Indiana Univ Sch Med, Riley Hosp Children, Indianapolis, IN 46202 USA

[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA

[3] Stanford Univ, Lucile Salter Packard Childrens Hosp, Palo Alto, CA 94304 USA

[4] Yale New Haven Childrens Hosp, New Haven, CT USA

[5] New Hampshires Hosp Children, Manchester, Lancs, England

[6] Univ Minnesota, Masonic Childrens Hosp, Minneapolis, MN USA

[7] AbbVie, N Chicago, IL USA

[8] Univ Vermont, Childens Hosp, Burlington, VT 05405 USA

[9] ImproveCareNow, Burlington, VT USA

来源：

JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷

关键词：

D O I：

10.1093/ecco-jcc/jjx002.024

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OP025

引用

下载

页码：S15 / S16

页数：2

共 50 条

[21] High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease
Ebach, Dawn R.
Jester, Traci W.
Galanko, Joseph A.
Firestine, Ann M.
Ammoury, Rana
Cabrera, Jose
Bass, Julie
Minar, Phillip
Olano, Kelly
Margolis, Peter
Sandberg, Kelly
Linnville, Tiffany M.
Kaplan, Jess
Pitch, Lisa
Steiner, Steven J.
Bass, Dorsey
Moses, Jonathan
Adler, Jeremy
Gulati, Ajay S.
Wali, Prateek
Pashankar, Dinesh
Ivanova, Anastasia
Herfarth, Hans
Wohl, David A.
Benkov, Keith J.
Strople, Jennifer
Sullivan, Jillian
Tung, Jeanne
Molle-Rios, Zorela
Saeed, Shehzad A.
Bousvaros, Athos
Kappelman, Michael D.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (06): : 1110 - 1116
[22] Anti-tumor necrosis factor therapy for pediatric Crohn's disease in Australia doubled between 2015 and 2021
Gawade, G.
Massuger, W.
Giles, E.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 239 - 239
[23] Treatment of pediatric Crohn's disease (CD) with anti-tumor necrosis factor α chimeric monoclonal antibody (infliximab)
Kugathansan, S
Rivera, MT
Martinez, A
Binion, DG
Werlin, SL
GASTROENTEROLOGY, 1999, 116 (04) : A755 - A755
[24] Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor a Antibodies
Bamberger, Sarah
Vinson, Christine Martinez
Mohamed, Damir
Viala, Jerome
Carel, Jean-Claude
Hugot, Jean-Pierre
Simon, Dominique
PLOS ONE, 2016, 11 (09):
[25] Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab
Korzenik, JR
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 285 - +
[26] Demyelination during anti-tumor necrosis factor α therapy with infliximab for Crohn's disease
Thomas, CW
Weinshenker, BG
Sandborn, WJ
INFLAMMATORY BOWEL DISEASES, 2004, 10 (01) : 28 - 31
[27] Functional modulation of crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies
Di Sabatino, Antonio
Pender, Sylvia L. F.
Jackson, Claire L.
Prothero, Joanna D.
Gordon, John N.
Picariello, Lucia
Rovedatti, Laura
Docena, Guillermo
Monteleone, Giovanni
Rampton, David S.
Tonelli, Francesco
Corazza, Gino R.
Macdonald, Thomas T.
GASTROENTEROLOGY, 2007, 133 (01) : 137 - 149
[28] Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease
Laurie S. Conklin
Bernard Cohen
Lindsay Wilson
Carmen Cuffari
Maria Oliva-Hemker
Nature Reviews Gastroenterology & Hepatology, 2010, 7 : 174 - 177
[29] Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
Suenaert, P
Bulteel, V
Lemmens, L
Noman, M
Geypens, B
Van Assche, G
Geboes, K
Ceuppens, JL
Rutgeerts, P
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (08): : 2000 - 2004
[30] Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease
Conklin, Laurie S.
Cohen, Bernard
Wilson, Lindsay
Cuffari, Carmen
Oliva-Hemker, Maria
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (03) : 174 - 177

← 1 2 3 4 5 →